Centro Oncologico de Chihuahua

Chihuahua City 31217

1 studies enrolling now · 4 studies all time

What they study most

Carcinoma, Non-Small-Cell Lung, Chemotherapy-Induced Nausea and Vomiting, Colorectal Neoplasms, Mesothelioma

Studies at this site

• A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy — Recruiting now
• A Study of Combination Amivantamab and Carboplatin-Pemetrexed Therapy, Compared With Carboplatin-Pemetrexed, in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Characterized by Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions — Running, not enrolling
• Nintedanib (BIBF 1120) in Mesothelioma — Stopped early
• An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting — Completed